25 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp04497 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | Yunnan firebelly toad | Membrane perforation | Cell viability assay | 486P(G4) | Bladder cancer | IC50 : 59.4 µM |
| dbacp04599 | Maximin 1 | GIGTKILGGVKTALKGALKELASTYAN | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04600 | Maximin 3 | GIGGKILSGLKTALKGAAKELASTYLH | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04601 | Maximin 4 | GIGGVLLSAGKAALKGLAKVLAEKYAN | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04602 | Maximin H1 | ILGPVISTIGGVLGGLLKNL | Yunnan firebelly toad | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp04603 | Maximin H1 | ILGPVISTIGGVLGGLLKNL | Yunnan firebelly toad, China, Asia | Not specified | MTT assay | C8166 | Bladder cancer | Not found |
| dbacp04604 | Maximin H1 | ILGPVISTIGGVLGGLLKNL | Yunnan firebelly toad, China, Asia | Not specified | MTT assay | BIU-87 | Bladder cancer | Not found |
| dbacp04605 | Maximin H1 | ILGPVISTIGGVLGGLLKNL | Yunnan firebelly toad, China, Asia | Not specified | MTT assay | T27 | Bladder cancer | Not found |
| dbacp04606 | Maximin H5 | ILGPVLGLVSDTLDDVLGIL | Yunnan firebelly toad, China, Asia | Cell membrane disintegration | Not specified | Not found | Not found | MIC : 80 μM |
| dbacp04607 | Maximin1 | GIGTKILGGVKTALKGALKELASTYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | C8166 | Leukemia cancer | IC50 : 15.3 µg/ml |
| dbacp04608 | Maximin1 | GIGTKILGGVKTALKGALKELASTYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 24.3 µg/ml |
| dbacp04609 | Maximin1 | GIGTKILGGVKTALKGALKELASTYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | BIU-87 | Bladder cancer | IC50 : 20.5 µg/ml |
| dbacp04610 | Maximin1 | GIGTKILGGVKTALKGALKELASTYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | T-24 | Bladder cancer | IC50 : 35.4 µg/ml |
| dbacp04611 | Maximin3 | GIGGKILSGLKTALKGAAKELASTYLH | Yunnan firebelly toad | Not specified | MTT/MTS assay | C8166 | Leukemia cancer | IC50 : 11.4 µg/ml |
| dbacp04612 | Maximin3 | GIGGKILSGLKTALKGAAKELASTYLH | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 25.2 µg/ml |
| dbacp04613 | Maximin3 | GIGGKILSGLKTALKGAAKELASTYLH | Yunnan firebelly toad | Not specified | MTT/MTS assay | BIU-87 | Bladder cancer | IC50 : 28 µg/ml |
| dbacp04614 | Maximin3 | GIGGKILSGLKTALKGAAKELASTYLH | Yunnan firebelly toad | Not specified | MTT/MTS assay | T-24 | Bladder cancer | IC50 : 18 µg/ml |
| dbacp04615 | Maximin4 | GIGVLLSAGKAALKGLAKVLAEKYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | C8166 | Leukemia cancer | IC50 : 24.2 µg/ml |
| dbacp04616 | Maximin4 | GIGVLLSAGKAALKGLAKVLAEKYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 53.4 µg/ml |
| dbacp04617 | Maximin4 | GIGVLLSAGKAALKGLAKVLAEKYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | BIU-87 | Bladder cancer | IC50 : >50 µg/ml |
| dbacp04618 | Maximin4 | GIGVLLSAGKAALKGLAKVLAEKYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | T-24 | Bladder cancer | IC50 : >50 µg/ml |
| dbacp04619 | Maximin5 | SIGAKILGGVKTFFKGALKELASTYLQ | Yunnan firebelly toad | Not specified | MTT/MTS assay | C8166 | Leukemia cancer | IC50 : 34.4 µg/ml |
| dbacp04620 | Maximin5 | SIGAKILGGVKTFFKGALKELASTYLQ | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : >50 µg/ml |
| dbacp04621 | Maximin5 | SIGAKILGGVKTFFKGALKELASTYLQ | Yunnan firebelly toad | Not specified | MTT/MTS assay | BIU-87 | Bladder cancer | IC50 : >50 µg/ml |
| dbacp04622 | Maximin5 | SIGAKILGGVKTFFKGALKELASTYLQ | Yunnan firebelly toad | Not specified | MTT/MTS assay | T-24 | Bladder cancer | IC50 : >50 µg/ml |